News | December 25, 2023
Lyndra Therapeutics raises US$101 million in Series E funding
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
